Desq Long
Sign in

Company

BELITE BIO, INC

BLTE · CIK 0001889109

SEC FORM 4
$427,414.02

BELITE BIO, INC (BLTE)

Sale of 2,200 shares at $194.2791 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$805,888.89

BELITE BIO, INC (BLTE)

Sale of 4,120 shares at $195.6041 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$879,199.67

BELITE BIO, INC (BLTE)

Sale of 4,475 shares at $196.4692 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$908,243.69

BELITE BIO, INC (BLTE)

Sale of 4,605 shares at $197.2299 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$507,392.31

BELITE BIO, INC (BLTE)

Sale of 2,562 shares at $198.0454 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$466,398.72

BELITE BIO, INC (BLTE)

Sale of 2,400 shares at $194.3328 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,191,325.19

BELITE BIO, INC (BLTE)

Sale of 6,090 shares at $195.6199 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,190,642.35

BELITE BIO, INC (BLTE)

Sale of 6,058 shares at $196.5405 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,727,274.59

BELITE BIO, INC (BLTE)

Sale of 8,752 shares at $197.3577 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$534,844.89

BELITE BIO, INC (BLTE)

Sale of 2,700 shares at $198.0907 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$294,200.79

BELITE BIO, INC (BLTE)

Sale of 1,633 shares at $180.1597 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,173,191.28

BELITE BIO, INC (BLTE)

Sale of 6,200 shares at $189.2244 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$343,139.58

BELITE BIO, INC (BLTE)

Sale of 1,800 shares at $190.6331 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,184,753.66

BELITE BIO, INC (BLTE)

Sale of 6,200 shares at $191.0893 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$653,788.11

BELITE BIO, INC (BLTE)

Sale of 3,398 shares at $192.4038 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$888,727.20

BELITE BIO, INC (BLTE)

Sale of 4,602 shares at $193.1176 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$362,106.60

BELITE BIO, INC (BLTE)

Sale of 2,000 shares at $181.0533 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$364,985.20

BELITE BIO, INC (BLTE)

Sale of 2,000 shares at $182.4926 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$688,899.15

BELITE BIO, INC (BLTE)

Sale of 3,759 shares at $183.2666 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$658,743.54

BELITE BIO, INC (BLTE)

Sale of 3,569 shares at $184.5737 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$717,407.64

BELITE BIO, INC (BLTE)

Sale of 3,872 shares at $185.2809 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$857,187.00

BELITE BIO, INC (BLTE)

Sale of 4,600 shares at $186.345 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$729,941.55

BELITE BIO, INC (BLTE)

Sale of 3,900 shares at $187.1645 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$358,317.96

BELITE BIO, INC (BLTE)

Sale of 1,900 shares at $188.5884 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386790 · filed 2026-09-09 · View filing →

SEC FORM 4
$475,071.26

BELITE BIO, INC (BLTE)

Sale of 2,635 shares at $180.2927 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,695,552.24

BELITE BIO, INC (BLTE)

Sale of 8,955 shares at $189.3414 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$114,232.02

BELITE BIO, INC (BLTE)

Sale of 600 shares at $190.3867 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$2,117,908.76

BELITE BIO, INC (BLTE)

Sale of 11,080 shares at $191.1470 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$810,411.80

BELITE BIO, INC (BLTE)

Sale of 4,209 shares at $192.5426 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,566,439.31

BELITE BIO, INC (BLTE)

Sale of 8,111 shares at $193.1253 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$468,876.68

BELITE BIO, INC (BLTE)

Sale of 2,587 shares at $181.2434 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$622,869.09

BELITE BIO, INC (BLTE)

Sale of 3,413 shares at $182.4990 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$908,228.21

BELITE BIO, INC (BLTE)

Sale of 4,955 shares at $183.2953 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,153,646.55

BELITE BIO, INC (BLTE)

Sale of 6,252 shares at $184.5244 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$851,286.37

BELITE BIO, INC (BLTE)

Sale of 4,593 shares at $185.3443 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,453,323.30

BELITE BIO, INC (BLTE)

Sale of 7,800 shares at $186.3235 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,160,964.26

BELITE BIO, INC (BLTE)

Sale of 6,200 shares at $187.2523 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$573,252.92

BELITE BIO, INC (BLTE)

Sale of 3,045 shares at $188.2604 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386794 · filed 2026-09-09 · View filing →

SEC FORM 4
$25,560.00

BELITE BIO, INC (BLTE)

Sale of 142 shares at $180 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001193125-26-350217 · filed 2026-08-14 · View filing →

SEC FORM 4
$40,267.11

BELITE BIO, INC (BLTE)

Sale of 223 shares at $180.57 per share.

Reporting Person Lin Yu-Hsin · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001193125-26-350217 · filed 2026-08-14 · View filing →

SEC FORM 4
$25,920.00

BELITE BIO, INC (BLTE)

Sale of 144 shares at $180 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001193125-26-350218 · filed 2026-08-14 · View filing →

SEC FORM 4
$40,267.11

BELITE BIO, INC (BLTE)

Sale of 223 shares at $180.57 per share.

Reporting Person Chuang Hao-Yuan · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001193125-26-350218 · filed 2026-08-14 · View filing →